Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 23, 2006. The report serves as a notice of the company's Annual General Meeting (AGM) scheduled for May 17, 2006, and announces the availability of the 2005 Annual Report and 2005 Annual Review.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding the AGM and the release of the 2005 Annual Report, rather than a financial results statement.
Material Changes
No material financial changes or comparative period data are disclosed in this specific filing text.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly details the logistics of the upcoming AGM and the submission of the 2005 Annual Report to the UK Listing Authority.
Investor Verification Checklist
- Verify the date and location of the Annual General Meeting (May 17, 2006, London).
- Access the 2005 Annual Report and 2005 Annual Review via the company website (www.gsk.com) or the UK Listing Authority for detailed financial data.
- Confirm the availability of the Notice of Annual General Meeting at the Financial Services Authority Document Viewing Facility.